Search results for "vaccines" in Articles / App Notes
Article
mRNA Vaccines: Current Trends and Perspectives
Read more >>
mRNA therapy is a rapidly growing field. The technology offers great benefit and potential for infectious diseases and personalized medicines due to its advantages in flexibility, co…
Article
Capto™ Core 700 in Vaccine Processing
The aim with this white paper is to discuss the advantages of using Capto Core 700 in virus purification compared to size exclusion chromatography (SEC), a technique commonly used in several vaccine…
Article
Analysis of mRNA Therapeutics and Vaccines
Analytical approaches must keep pace to ensure the identity, safety, and efficacy of evolving mRNA candidates.
Read more here >>>
Article
mRNA Processing Workflow for Vaccines and Therapeutics
CLICK HERE TO VIEW >>
Learn more on key considerations when setting up a messenger RNA (mRNA) process with this infographic.
Article
Overview of a scale-up of a cell-based influenza virus production process using ReadyToProcess equipment
The objective of WHO’s global action plan (GAP) for influenza vaccines is to produce enough seasonal flu vaccine to immunize two billion people by 2015 (1). If facing a pandemic, the world would need …
Article
Maximum Output Starts with Optimized Upstream Processing
Viral vectors are a special case
Viral vectors, which are used directly in therapeutics and vaccines and also in the production of gene and gene-modified cell therapies, represent a special case…
Article
Virus-like Particles as Therapeutic Moieties of the Future
Vaccine development
Traditional viral vaccines, which are based on inactivated or attenuated infectious virus, are difficult to produce and may cause adverse reactions in immunocompromised patient…
Article
Biopharma Manufacturers Respond to Ebola Crisis
Vaccine industry executives and biotech innovators joined the discussion about conducting effective and ethical clinical trials and ramping up production of promising vaccines and therapies. A main ai…
Article
Addressing the Challenges in Downstream Processing Today and Tomorrow
…lopment of antibody fragments, nanobodies, biosimilar protein therapeutics, conjugated proteins and vaccines, Fc-fusions, and nonantibody protein scaffolds. In addition to high cell density mammalian…
Article
Strategizing for Rapid Changeovers in Biologics Manufacturing
For certain biologics, most notably viral vectors, vaccines based on live viruses, and spore-formers, precautions must be taken to prevent spread through the air and more extensive cleaning protocols …